Announcements Trials
Browse Landscape

Phase

Phase 1/2 6Phase 1 2Phase NA 1Phase 3 1Phase 2/3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Glioblastoma 4Pancreatic Neoplasms 3Multiple Myeloma 3Neoplasms 2Glioma 2Thrombocythemia, Essential 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Oligodendroglioma 1Obesity 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Leukemia 1Gliosarcoma 1Colorectal Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Ascorbic Acid × Clear all
NCT01833351 2015-11-06

Evaluation of Intravenous Ascorbic Acid

University of Kansas Medical Center

Phase 1 Completed
34 enrolled
Tumor-Agnostic

Neoplasms

NCT00441207 2013-04-23

Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors

Midwestern Regional Medical Center

Phase 1 Completed
18 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡